524
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, spectral characterization, antioxidant, anticancer in vitro, and DNA cleavage studies of a series of ruthenium(II) complexes bearing Schiff base ligands

, , , &
Pages 4052-4066 | Received 08 May 2013, Accepted 08 Oct 2013, Published online: 26 Nov 2013
 

Abstract

Ruthenium(II) complexes with 2-acetylpyridine-thiosemicarbazones (L1–L4) were synthesized and characterized by analytical and spectral (FT-IR, UV–vis, NMR [1H, 13C and 31P], and ESI-Mass) methods. Systematic biological investigations, free radical scavenging, anticancer activities, and DNA cleavage studies, were carried out for the complexes. Antioxidant studies showed that the complexes have significant antioxidant activity against DPPH, hydroxyl, nitric oxide radicals and hydrogen peroxide assay. The in vitro cytotoxicity of complexes against breast cancer (MCF-7) cell line was assayed showing high cytotoxicity with low IC50 values indicating their efficiency in destroying the cancer cells even at very low concentrations. The DNA cleavage studies showed that the complexes efficiently cleaved DNA.

Acknowledgement

We are thankful to the IISC Bangalore, STIC Cochin, SAIF Panjab University, Chandigarh, KMCH Coimbatore, and Biogenics Research and Training Center in Biotechnology, Hubli, India for providing instrumental facilities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.